What we're about

JLM-BioCity is the non-profit forum of bio professionals who love Jerusalem and want to make Jerusalem a global bio leader by creating networking opportunities to attract research and innovation while creating jobs in the bio and life science fields. Our mission is to make Jerusalem a great place for the application of bio opportunities for the benefit of mankind.

Join the JLM-BioCity forum - the forum of Bio and pharma professionals in the Jerusalem area. We have over 1500 members and meet during the year about once every 2 months to network. To be on our mailing list, join us. In this way, you join the JLM Bio community!

You can see our past events there too. 

We hope to see you at the next meeting on Oct 2nd on "Is SYN BIO creating a FOODTECH revolution?" at 17:30 p.m. Israel time at Azrieli College in Jerusalem
https://www.meetup.com/jlm-biocity/events/287140477/

You are also invited to join the JLM-BioCity LinkedIn page https://www.linkedin.com/groups/7060787 which is focused on the bio news in the JLM area
and 
the JLM-BioCity Facebook group https://www.facebook.com/groups/biomed.jbnf/
For more information, see https://jlm-biocity.org

Upcoming events (1)

JLM-BioCity Pharma and Biotech Pitch Event

Azrieli College of Engineering Jerusalem

JLM-BioCity Pharma and Biotech Pitch Event
Wednesday, January 4th, 2023

JLM-BioCity is organizing an evening event for both Biomed and Pharma Startups pitching to a panel of leading investors:

Dr Yael Gruenbaum-Cohen, Venture Partner, aMoon
Dr Ori Choshen, CEO, VLX Ventures
Goozy Hartog, Principal, Pontifax

During the event, 6-7 startups get to pitch to multiple investors and a live audience, gain some valuable exposure, and get some equally valuable feedback. You will network, you will potentially build partnerships but, most importantly, you will get a chance to secure funding and accelerate your business. All pharma and biotech startups are invited to send in an executive summary before Dec 28th to [masked] so that the panel will select the startups they prefer.

JLM-BioCity is delighted to announce this event is sponsored by Azrieli College of Engineering and, Atobe, Azrieli College's Startup Entrepreneurship Center.

Presentations will be in English.

The meeting will have both before and after the formal part, networking that JLM-BioCity is famous for. We will work to make introductions so that every participant will go away with at least 5 good leads!

Please RSVP as soon as possible.

NOTE: We ask you for a 20 NIS cash donation at the entrance to the event. The JLM-BioCity Team are all volunteers, but we have expenses to cover. Thank you for your donation in advance.

PLEASE FILL OUT IN HEBREW THE GOOGLE FORM TO GET ENTRANCE TO THE AZRIELI COLLEGE to https://forms.gle/uiNQFL9sACJLeWPt6

About the panelists:

  • DR YAEL GRUENBAUM-COHEN, Venture Partner, aMoon
    Prior to joining aMoon, Yael was a General at Medison Ventures, leading licensing, investments, and strategic collaborations with global pharmaceutical companies and academic institutes. Before then Yael led medical affairs for the Rare Disease division at Medison Pharma. With academic degrees in molecular genetics (Ph.D., Postdoc) and a DMD from the Hebrew University of Jerusalem and the Weizmann Institute of Sciences
  • ORI CHOSHEN, CEO, VLX Ventures
    Builds innovation platforms and establishes and invests in innovative startups in the biotech and computational biology industries. Prior to joining VLX Ventures, Ori served as VP of Business Development at Xenia VC and as a Director of Business Development at SanDisk, (NSDQ: SNDK) where he managed the Ecosystem Group. Ori joined SanDisk as part of the company’s $1.6 billion acquisition of M-Systems (NSDQ: FLSH) in 2006. Prior to this, Ori held business development and management positions at M-Systems and Hutchison’s global telecom group. Ori holds a B.A. in Philosophy, Cum Laude, and an LLB degree from Tel Aviv University as well as an MBA, Cum Laude, from the Solvay Business School in Brussels.
  • DR GOOZY HARTOG, Principal, Pontifax
    Joined Pontifax in 2022 to co-manage our venture debt fund, as well as to manage and source pipeline deal flow. Also manages Pontifax’s venture debt portfolio and leads business development initiatives. Prior to joining Pontifax Goozy spent 5 years at Medison Ventures filling various strategy, investment, and BD roles. Goozy also spent 2 years at the Boston Consulting Group NYC and Tel Aviv offices, focusing on engagements with global pharmaceutical companies. Goozy obtained his Ph.D. in Neurobiology from the New York Medical College, studying the biochemistry of Post-Traumatic Stress Disorder.

1

Past Events

Is SynBio Starting A Foodtech Revolution?

Azrieli College of Engineering Jerusalem

Photos (2,610)